Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping

被引:0
|
作者
Paul Jackson
Iris Mastrangelo
Michael Reed
Peter Tegtmeyer
Gina Yardley
Julie Barrett
机构
[1] Oncology Research Centre,Biology Department
[2] Prince of Wales Hospital,Department of Molecular Genetics and Microbiology
[3] Brookhaven National Laboratory,undefined
[4] University Medical Center,undefined
[5] State University of New York Stony Brook,undefined
来源
Oncogene | 1998年 / 16卷
关键词
P53; MCK; transcription; DNA looping;
D O I
暂无
中图分类号
学科分类号
摘要
The WAF1, Cyclin G and muscle creatine kinase (MCK) genes, all contain multiple copies of the consensus p53-binding element within their regulatory regions. We examined the role of these elements in transactivation of the muscle creatine kinase (MCK) gene by p53. The MCK promoter possesses distal (−3182 to −3133) and proximal (−177 to −81) p53-binding elements within which residues −3182 to −3151 (distal) and −176 to −149 (proximal) show homology to the consensus p53-binding site. Using promoter deletion studies, we find that both proximal and distal elements are required for high level, synergistic transcriptional activation in vivo. Electron microscopy indicates that p53-p53 interactions link proximal and distal p53-binding elements and cause looping out of intervening DNA, suggesting that this DNA sequence may be dispensable for synergy. This idea was confirmed by progressive deletion of the DNA between p53-binding elements. Synergism persisted with spacing reduced to only 150 bp. Tetramerization-deficient p53 mutants were defective for transcriptional activation but still capable of synergy. Our results provide evidence for a model by which high level transcriptional activation of promoters with multiple p53 response elements is achieved.
引用
收藏
页码:283 / 292
页数:9
相关论文
共 50 条
  • [41] Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets
    Ma, Buyong
    Pan, Yongping
    Zheng, Jie
    Levine, Arnold J.
    Nussinov, Ruth
    NUCLEIC ACIDS RESEARCH, 2007, 35 (09) : 2986 - 3001
  • [42] The impact of DNA structure and flexibility of p53 response elements with long spacers on p53 recognition of its binding sites
    Zivan, A.
    Haran, T. E.
    FEBS JOURNAL, 2017, 284 : 265 - 265
  • [43] Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage
    Lestari, Widya
    Ichwan, Solachuddin J. A.
    Otsu, Megumi
    Yamada, Shumpei
    Iseki, Sachiko
    Shimizu, Shihoko
    Ikeda, Masa-Aki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (02) : 710 - 716
  • [44] The role of P53 in DNA damage response and apoptosis
    Oren, M
    Lidor, E
    Minsky, N
    Stambolsky, P
    Taplick, J
    Wang, XJ
    Weisz, L
    Zalcenstein, A
    Rotter, V
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 166 - 167
  • [45] Regulation of the DNA Damage Response by p53 Cofactors
    Zhang, Xiao-Peng
    Liu, Feng
    Wang, Wei
    BIOPHYSICAL JOURNAL, 2012, 102 (10) : 2251 - 2260
  • [46] ARSENITE INTERFERES WITH P53 RESPONSE TO DNA DAMAGE
    Zhang, Jiang Lin
    Huang, Ye Lin
    Dibble, Christian
    McHenry, Kevin
    Kim, Mihee
    Yuan, Zhi Min
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S39 - S39
  • [47] Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage
    Kathleen M Dohoney
    Claire Guillerm
    Craig Whiteford
    Cem Elbi
    Paul F Lambert
    Gordon L Hager
    John N Brady
    Oncogene, 2004, 23 : 49 - 57
  • [48] p53 partners with RNA in the DNA damage response
    Huarte, Maite
    NATURE GENETICS, 2016, 48 (11) : 1298 - 1299
  • [49] p53 partners with RNA in the DNA damage response
    Maite Huarte
    Nature Genetics, 2016, 48 : 1298 - 1299
  • [50] Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage
    Dohoney, KM
    Guillerm, C
    Whiteford, C
    Elbi, C
    Lambert, PF
    Hager, GL
    Brady, JN
    ONCOGENE, 2004, 23 (01) : 49 - 57